Skip to main navigation Skip to search Skip to main content

Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest

  • Ying Ti Wang
  • , Hsiao Sheng Liu
  • , Chun Li Su*
    • *Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    32   Link opens in a new tab Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest'. Together they form a unique fingerprint.
    Sort by

    INIS

    Biochemistry, Genetics and Molecular Biology

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology